Gene-environment interaction in major depression: Focus on experience-dependent biological systems

Frontiers in Psychiatry

Volumn 6, Issue MAY, 2015, Pages

  Lopizzo, Nicola ^a   Chiavetto, Luisella Bocchio ^a,b   Cattane, Nadia ^a   Plazzotta, Giona ^a   Tarazi, Frank I ^c   Pariante, Carmine M ^d   Riva, Marco A ^e   Cattaneo, Annamaria ^a,d  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b ECAMPUS UNIVERSITY   (Italy)

^c MCLEAN HOSPITAL   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Depression; DNA methylation; miRNAs; Stressful life events; Vulnerability genes

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN; DNA; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 124A; MICRORNA 132; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

5 HTTLPR GENE; BDNF GENE; BRAIN SIZE; COPY NUMBER VARIATION; DNA METHYLATION; EPIGENETICS; FKBP5 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; GR GENE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MENTAL STRESS; NERVE CELL PLASTICITY; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84930684879     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00068     Document Type: Review

References (153)

1. Shenal BV, Harrison DW, Demaree HA. The neuropsychology of depression: a literature review and preliminary model. Neuropsychol Rev (2003) 13:33-42. doi:10.1023/A:1022300622902
2. Reddy MS. Depression: the disorder and the burden. Indian J Psychol Med (2010) 32:1-2. doi:10.4103/0253-7176.70510
3. World Health Organization. The World Health Report 2001 - Mental Health: New Understanding. New Hope (2001).
4. Kessler D, Sharp D, Lewis G. Screening for depression in primary care. Br J Gen Pract (2005) 55:659-60.
5. Sibille E, French B. Biological substrates underpinning diagnosis of major depression. Int J Neuropsychopharmacol (2013) 16(8):1893-909. doi:10.1017/S1461145713000436
6. Lotan A, Fenckova M, Bralten J, Alttoa A, Dixson L, Williams RW, et al. Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front Neurosci (2014) 8:331. doi:10.3389/fnins.2014.00331
7. Lohoff FW. Overview of the genetics of major depressive disorder. Curr Psychiatry Rep (2010) 12:539-46. doi:10.1007/s11920-010-0150-6
8. Lesch KP. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci (2004) 29:174-84.
9. Züchner S, Roberts ST, Speer MC, Beckham JC. Update on psychiatric genetics. Genet Med (2007) 9:332-40. doi:10.1097/GIM.0b013e318065a9fa
10. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry (2000) 157:1552-62. doi:10.1176/appi.ajp.157.10.1552
11. Menke A, Domschke K, Czamara D, Klengel T, Hennings J, Lucae S, et al. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology (2012) 37:797-807. doi:10.1038/npp.2011.257
12. Bogdan R, Nikolova YS, Pizzagalli DA. Neurogenetics of depression: a focus on reward processing and stress sensitivity. Neurobiol Dis (2013) 52:12-23. doi:10.1016/j.nbd.2012.05.007
13. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2008) 13:772-85. doi:10.1038/sj.mp.4002088
14. Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, et al. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease. Biol Psychiatry (1998) 43:159-64. doi:10.1016/S0006-3223(97)00326-0
15. Baba H, Nakano Y, Maeshima H, Satomura E, Kita Y, Suzuki T, et al. Metabolism of amyloid-beta protein may be affected in depression. J Clin Psychiatry (2012) 73:115-20. doi:10.4088/JCP.10m06766
16. Namekawa Y, Baba H, Maeshima H, Nakano Y, Satomura E, Takebayashi N, et al. Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Abeta protein metabolism. Prog Neuropsychopharmacol Biol Psychiatry (2013) 43:203-8. doi:10.1016/j.pnpbp.2012.12.016
17. Sullivan PF, De Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2009) 14:359-75. doi:10.1038/mp.2008.125
18. Verbeek EC, Bevova MR, Bochdanovits Z, Rizzu P, Bakker IM, Uithuisje T, et al. Resequencing three candidate genes for major depressive disorder in a Dutch cohort. PLoS One (2013) 8:e79921. doi:10.1371/journal.pone.0079921
19. Woudstra S, Van Tol MJ, Bochdanovits Z, Van Der Wee NJ, Zitman FG, Van Buchem MA, et al. Modulatory effects of the piccolo genotype on emotional memory in health and depression. PLoS One (2013) 8:e61494. doi:10.1371/journal.pone.0061494
20. McFarquhar M, Elliott R, Mckie S, Thomas E, Downey D, Mekli K, et al. TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder. Neuropsychopharmacology (2014) 39:1743-53. doi:10.1038/npp.2014.22
21. Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, et al. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimers Dement (2012) 8:381-8. doi:10.1016/j.jalz.2011.10.005
22. Cao MQ, Hu SY, Zhang CH, Xia DS. Study on the interrelationship between 5-HTTLPR/G-protein beta3 subunit (C825T) polymorphisms and depressive disorder. Psychiatr Genet (2007) 17:233-8. doi:10.1097/YPG.0b013e3280c1e5de
23. Hu Q, Zhang SY, Liu F, Zhang XJ, Cui GC, Yu EQ, et al. Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis. J Affect Disord (2014) 172C:103-9. doi:10.1016/j.jad.2014.09.039
24. Klenke S, Kussmann M, Siffert W. The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics (2011) 21:594-606. doi:10.1097/FPC.0b013e3283491153
25. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet (1997) 74:526-8. doi:10.1002/(SICI)1096-8628(19970919)74:5<526::AID-AJMG14>3.0.CO;2-E
26. Wang X, Wang Z, Wu Y, Yuan Y, Hou Z, Hou G. Association analysis of the catechol-O-methyltransferase/methylenetetrahydrofolate reductase genes and cognition in late-onset depression. Psychiatry Clin Neurosci (2014) 68:344-52. doi:10.1111/pcn.12133
27. Dorado P, Penas-Lledo EM, Gonzalez AP, Caceres MC, Cobaleda J, Llerena A. Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele. Fundam Clin Pharmacol (2007) 21:451-3. doi:10.1111/j.1472-8206.2007.00501.x
28. Matsumoto Y, Fabbri C, Pellegrini S, Porcelli S, Politi P, Bellino S, et al. Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder. Mol Diagn Ther (2014) 18:567-77. doi:10.1007/s40291-014-0110-7
29. Gatt JM, Burton KL, Williams LM, Schofield PR. Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res (2015) 60C:1-13. doi:10.1016/j.jpsychires.2014.09.014
30. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, et al. Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry (2011) 16:516-32. doi:10.1038/mp.2010.38
31. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry (2010) 15:589-601. doi:10.1038/mp.2008.131
32. Hirschhorn N. Creativity and affective illness. Am J Psychiatry (2002) 159:677. doi:10.1176/appi.ajp.159.4.677
33. Munafo MR, Clark TG, Roberts KH, Johnstone EC. Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression. Neuropsychobiology (2006) 53:1-8. doi:10.1159/000089915
34. Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR, et al. Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it? Biol Psychiatry (2014) 76:510-2. doi:10.1016/j.biopsych.2014.07.029
35. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, Nyholt DR, et al. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry (2012) 17:36-48. doi:10.1038/mp.2010.109
36. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry (2011) 16:193-201. doi:10.1038/mp.2009.124
37. Kloiber S, Czamara D, Karbalai N, Muller-Myhsok B, Hennings J, Holsboer F, et al. ANK3 and CACNA1C - missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. J Psychiatr Res (2012) 46:973-9. doi:10.1016/j.jpsychires.2012.04.017
38. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2013) 18:497-511. doi:10.1038/mp.2012.21
39. Comasco E, Åslund C, Oreland L, Nilsson KW. Three-way interaction effect of 5-HTTLPR, BDNF Val66Met, and childhood adversity on depression: a replication study. Eur Neuropsychopharmacol (2013) 23:1300-6. doi:10.1016/j.euroneuro.2013.01.010
40. Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology (2011) 36:1982-91. doi:10.1038/npp.2011.81
41. Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M, et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry (2011) 168:1107-16. doi:10.1176/appi.ajp.2011.10111577
42. Vinberg M, Trajkovska V, Bennike B, Knorr U, Knudsen GM, Kessing LV. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology (2009) 34:1380-9. doi:10.1016/j.psyneuen.2009.04.014
43. Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med (2009) 39:1425-32. doi:10.1017/S0033291709005248
44. Bet PM, Penninx BW, Bochdanovits Z, Uitterlinden AG, Beekman AT, Van Schoor NM, et al. Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: new evidence for a gene-environment interaction. Am J Med Genet B Neuropsychiatr Genet (2009) 150B:660-9. doi:10.1002/ajmg.b.30886
45. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci (2008) 28:389-98. doi:10.1111/j.1460-9568.2008.06332.x
46. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 299:1291-305. doi:10.1001/jama.299.11.1291
47. Kumsta R, Entringer S, Koper JW, Van Rossum EF, Hellhammer DH, Wust S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol Psychiatry (2007) 62:863-9. doi:10.1016/j.biopsych.2007.04.013
48. Wüst S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab (2004) 89:565-73. doi:10.1210/jc.2003-031148
49. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 301:386-9. doi:10.1126/science.1083968
50. Uher R. Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search. Soc Psychiatry Psychiatr Epidemiol (2014) 49:3-14. doi:10.1007/s00127-013-0801-0
51. Lin YL, Wang S. Prenatal lipopolysaccharide exposure increases depression-like behaviors and reduces hippocampal neurogenesis in adult rats. Behav Brain Res (2014) 1(259):24-34. doi:10.1016/j.bbr.2013.10.034
52. Gámez-Guadix M, Orue I, Smith PK, Calvete E. Longitudinal and reciprocal relations of cyberbullying with depression, substance use, and problematic internet use among adolescents. J Adolesc Health (2013) 53(4):446-52. doi:10.1016/j.jadohealth.2013.03.030
53. Gullander M, Hogh A, Hansen ÅM, Persson R, Rugulies R, Kolstad HA, et al. Exposure to workplace bullying and risk of depression. J Occup Environ Med (2014) 56(12):1258-65. doi:10.1097/JOM.0000000000000339
54. Cummings CM, Caporino NE, Kendall PC. Comorbidity of anxiety and depression in children and adolescents: 20 years after. Psychol Bull (2014) 140(3):816-45. doi:10.1037/a0034733
55. Feingold D, Weiser M, Rehm J, Lev-Ran S. The association between cannabis use and mood disorders: A longitudinal study. J Affect Disord (2014) 172C:211-8. doi:10.1016/j.jad.2014.10.006
56. Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol (2012) 233:102-11. doi:10.1016/j.expneurol.2011.10.032
57. Booij SH, Bos EH, De Jonge P, Oldehinkel AJ. Markers of stress and inflammation as potential mediators of the relationship between exercise and depressive symptoms: findings from the TRAILS study. Psychophysiology (2014) 52(3):352-8. doi:10.1111/psyp.12329
58. Davis DA, Bortolato M, Godar SC, Sander TK, Iwata N, Pakbin P, et al. Prenatal exposure to urban air nanoparticles in mice causes altered neuronal differentiation and depression-like responses. PLoS One (2013) 8:e64128. doi:10.1371/journal.pone.0064128
59. Hornung OP, Heim CM. Gene-environment interactions and intermediate phenotypes: early trauma and depression. Front Endocrinol (2014) 5:14. doi:10.3389/fendo.2014.00014
60. Ming X, Julu PO, Wark J, Apartopoulos F, Hansen S. Discordant mental and physical efforts in an autistic patient. Brain Dev (2004) 26(8):519-24.
61. Garner AS, Shonkoff JP; Committee on Psychosocial Aspects of Child and Family Health, Committee on Early Childhood, Adoption, and Dependent Care, Section on Developmental and Behavioral Pediatrics. Early childhood adversity, toxic stress, and the role of the pediatrician: translating developmental science into lifelong health. Pediatrics (2012) 129:e224-31.
62. Danese A, McEwen BS. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav (2012) 106:29-39. doi:10.1016/j.physbeh.2011.08.019
63. Shonkoff JP, Garner AS; Committee on Psychosocial Aspects of Child and Family Health, Committee on Early Childhood, Adoption, and Dependent Care, Section on Developmental and Behavioral Pediatrics. The lifelong effects of early childhood adversity and toxic stress. Pediatrics (2012) 129:e232-46. doi:10.1542/peds.2011-2663
64. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord (2004) 82:217-25. doi:10.1016/j.jad.2003.12.013
65. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the adverse childhood experiences study. JAMA (2001) 286:3089-96. doi:10.1001/jama.286.24.3089
66. Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry (1999) 4:163-72. doi:10.1038/sj.mp.4000473
67. Tyrka AR, Wier L, Price LH, Ross NS, Carpenter LL. Childhood parental loss and adult psychopathology: effects of loss characteristics and contextual factors. Int J Psychiatry Med (2008) 38:329-44. doi:10.2190/PM.38.3.h
68. Lizardi H, Klein DN, Ouimette PC, Riso LP, Anderson RL, Donaldson SK. Reports of the childhood home environment in early-onset dysthymia and episodic major depression. J Abnorm Psychol (1995) 104:132-9. doi:10.1037/0021-843X.104.1.132
69. Brook CA, Schmidt LA. Social anxiety disorder: a review of environmental risk factors. Neuropsychiatr Dis Treat (2008) 4:123-43.
70. Mirescu C, Peters JD, Gould E. Early life experience alters response of adult neurogenesis to stress. Nat Neurosci (2004) 7:841-6. doi:10.1038/nn1290
71. Mann JJ, Currier DM. Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression. Eur Psychiatry (2010) 25:268-71. doi:10.1016/j.eurpsy.2010.01.009
72. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA (2009) 301:2462-71. doi:10.1001/jama.2009.878
73. Dalton ED, Hammen CL, Najman JM, Brennan PA. Genetic susceptibility to family environment: BDNF Val66met and 5-HTTLPR influence depressive symptoms. J Fam Psychol (2014) 28:947-56. doi:10.1037/fam0000032
74. Sharpley CF, Palanisamy SK, Glyde NS, Dillingham PW, Agnew LL. An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings. Behav Brain Res (2014) 273:89-105. doi:10.1016/j.bbr.2014.07.030
75. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry (2011) 68:444-54. doi:10.1001/archgenpsychiatry.2010.189
76. Blakely RD, Veenstra-Vanderweele J. Genetic indeterminism, the 5-HTTLPR, and the paths forward in neuropsychiatric genetics. Arch Gen Psychiatry (2011) 68:457-8. doi:10.1001/archgenpsychiatry.2011.34
77. Wankerl M, Wust S, Otte C. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression? Curr Opin Psychiatry (2010) 23:582-7. doi:10.1097/YCO.0b013e32833f0e3a
78. Gao Z, Yuan H, Sun M, Wang Z, He Y, Liu D. The association of serotonin transporter gene polymorphism and geriatric depression: a meta-analysis. Neurosci Lett (2014) 578:148-52. doi:10.1016/j.neulet.2014.06.046
79. Zannas AS, McQuoid DR, Steffens DC, Chrousos GP, Taylor WD. Stressful life events, perceived stress, and 12-month course of geriatric depression: direct effects and moderation by the 5-HTTLPR and COMT Val158Met polymorphisms. Stress (2012) 15:425-34. doi:10.3109/10253890.2011.634263
80. Nestler EJ, Barrot M, Dileone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron (2002) 34:13-25. doi:10.1016/S0896-6273(02)00653-0
81. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci (2007) 10:1089-93. doi:10.1038/nn1971
82. Oral E, Canpolat S, Yildirim S, Gulec M, Aliyev E, Aydin N. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull (2012) 88:454-9. doi:10.1016/j.brainresbull.2012.03.005
83. Calabrese F, Molteni R, Racagni G, Riva MA. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology (2009) 34(Suppl 1):S208-16. doi:10.1016/j.psyneuen.2009.05.014
84. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 112:257-69. doi:10.1016/S0092-8674(03)00035-7
85. Rybakowski JK. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics (2008) 9:1589-93. doi:10.2217/14622416.9.11.1589
86. Baj G, Carlino D, Gardossi L, Tongiorgi E. Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. Front Neurosci (2013) 7:188. doi:10.3389/fnins.2013.00188
87. Post RM. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res (2007) 41:979-90. doi:10.1016/j.jpsychires.2006.09.009
88. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology (2005) 30:1353-61.
89. Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, et al. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport (2007) 18:1291-3. doi:10.1097/WNR.0b013e328273bcb0
90. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry (2009) 14:681-95. doi:10.1038/mp.2008.143
91. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med (2014) 12:7. doi:10.1186/1741-7015-12-7
92. Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology (2009) 34(Suppl 1):S186-95. doi:10.1016/j.psyneuen.2009.05.021
93. Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, Miller A, et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 10:1058-9. doi:10.1038/sj.mp.4001727
94. Koenen KC, Uddin M. FKBP5 polymorphisms modify the effects of childhood trauma. Neuropsychopharmacology (2010) 35:1623-4. doi:10.1038/npp.2010.60
95. Sun H, Kennedy PJ, Nestler EJ. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology (2013) 38:124-37. doi:10.1038/npp.2012.73
96. Levenson JM, Sweatt JD. Epigenetic mechanisms in memory formation. Nat Rev Neurosci (2005) 6:108-18. doi:10.1038/nrn1604
97. Miller CA, Campbell SL, Sweatt JD. DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem (2008) 89:599-603. doi:10.1016/j.nlm.2007.07.016
98. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci (2007) 8:355-67. doi:10.1038/nrn2132
99. Szyf M. Early life, the epigenome and human health. Acta Paediatr (2009) 98:1082-4. doi:10.1111/j.1651-2227.2009.01382.x
100. Lutz PE, Turecki G. DNA methylation and childhood maltreatment: from animal models to human studies. Neuroscience (2014) 264:142-56. doi:10.1016/j.neuroscience.2013.07.069
101. Meaney MJ, Ferguson-Smith AC. Epigenetic regulation of the neural transcriptome: the meaning of the marks. Nat Neurosci (2010) 13:1313-8. doi:10.1038/nn1110-1313
102. Kundakovic M. Postnatal risk environments, epigenetics, and psychosis: putting the pieces together. Soc Psychiatry Psychiatr Epidemiol (2014) 49:1535-6. doi:10.1007/s00127-014-0927-8
103. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci (2009) 12:342-8. doi:10.1038/nn.2270
104. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2013) 16:33-41. doi:10.1038/nn.3275
105. Provencal N, Suderman MJ, Guillemin C, Massart R, Ruggiero A, Wang D, et al. The signature of maternal rearing in the methylome in rhesus macaque prefrontal cortex and T cells. J Neurosci (2012) 32:15626-42. doi:10.1523/JNEUROSCI.1470-12.2012
106. Nieratschker V, Massart R, Gilles M, Luoni A, Suderman MJ, Krumm B, et al. MORC1 exhibits cross-species differential methylation in association with early life stress as well as genome-wide association with MDD. Transl Psychiatry (2014) 4:e429. doi:10.1038/tp.2014.75
107. Nagy C, Suderman M, Yang J, Szyf M, Mechawar N, Ernst C, et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol Psychiatry (2014) 20(3):320-8. doi:10.1038/mp.2014.21
108. Lucassen PJ, Naninck EFG, van Goudoever JB, Fitzsimons C, Joels M, Korosi A. Perinatal programming of adult hippocampal structure and function; emerging roles of stress, nutrition and epigenetics. Trends Neurosci (2013) 36:621-31. doi:10.1016/j.tins.2013.08.002
109. Serafini G, Hayley S, Pompili M, Dwivedi Y, Brahmachari G, Girardi P, et al. Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets? CNS Neurol Disord Drug Targets (2014) 13:1708-21. doi:10.2174/1871527313666141130223723
110. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol (2009) 21:452-60. doi:10.1016/j.ceb.2009.04.009
111. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet (2011) 12:99-110. doi:10.1038/nrg2936
112. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 11:597-610. doi:10.1038/nrg2843
113. O'Carroll D, Schaefer A. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology (2013) 38:39-54. doi:10.1038/npp.2012.87
114. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell (2009) 136:642-55. doi:10.1016/j.cell.2009.01.035
115. Watanabe K, Takai D. Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes. Front Genet (2013) 4:275. doi:10.3389/fgene.2013.00275
116. Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol (2013) 754:137-48. doi:10.1007/978-1-4419-9967-2_6
117. Hu W, Wang T, Xu J, Li H. MicroRNA mediates DNA methylation of target genes. Biochem Biophys Res Commun (2014) 444(4):676-81. doi:10.1016/j.bbrc.2014.01.171
118. Babenko O, Golubov A, Ilnytskyy Y, Kovalchuk I, Metz GA. Genomic and epigenomic responses to chronic stress involve miRNA-mediated programming. PLoS One (2012) 7:e29441. doi:10.1371/journal.pone.0029441
119. Uchida S, Hara K, Kobayashi A, Funato H, Hobara T, Otsuki K, et al. Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. J Neurosci (2010) 30:15007-18. doi:10.1523/JNEUROSCI.1436-10.2010
120. Suderman M, Borghol N, Pappas JJ, Pinto Pereira SM, Pembrey M, Hertzman C, et al. Childhood abuse is associated with methylation of multiple loci in adult DNA. BMC Med Genomics (2014) 7:13. doi:10.1186/1755-8794-7-13
121. Elfving B, Plougmann PH, Muller HK, Mathe AA, Rosenberg R, Wegener G. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol (2010) 13:563-72. doi:10.1017/S1461145709990721
122. Molteni R, Cattaneo A, Calabrese F, Macchi F, Olivier JD, Racagni G, et al. Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis (2010) 37:747-55. doi:10.1016/j.nbd.2009.12.014
123. Qiao H, An SC, Ren W, Ma XM. Progressive alterations of hippocampal CA3-CA1 synapses in an animal model of depression. Behav Brain Res (2014) 275:191-200. doi:10.1016/j.bbr.2014.08.040
124. Vinberg M, Bukh JD, Bennike B, Kessing LV. Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression? Psychiatry Res (2013) 210:102-8. doi:10.1016/j.psychres.2013.04.023
125. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology (2013) 38(3):377-85. doi:10.1038/npp.2012.191
126. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol Psychiatry (2014) 19:791-800. doi:10.1038/mp.2013.105
127. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry (2009) 65:760-9. doi:10.1016/j.biopsych.2008.11.028
128. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One (2011) 6:e23881. doi:10.1371/journal.pone.0023881
129. Kang HJ, Kim JM, Lee JY, Kim SY, Bae KY, Kim SW, et al. BDNF promoter methylation and suicidal behavior in depressive patients. J Affect Disord (2013) 151:679-85. doi:10.1016/j.jad.2013.08.001
130. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry (2010) 67:258-67. doi:10.1001/archgenpsychiatry.2010.9
131. Li YJ, Xu M, Gao ZH, Wang YQ, Yue Z, Zhang YX, et al. Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS One (2013) 8:e63648. doi:10.1371/journal.pone.0063648
132. Villanueva R. Neurobiology of major depressive disorder. Neural Plast (2013) 2013:873278. doi:10.1155/2013/873278
133. Philibert R. Merging genetic and environmental effects in the Iowa adoption studies: focus on depression. Ann Clin Psychiatry (2006) 18:219-22. doi:10.1080/10401230600948399
134. Ichise M, Vines DC, Gura T, Anderson GM, Suomi SJ, Higley JD, et al. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J Neurosci (2006) 26:4638-43. doi:10.1523/JNEUROSCI.5199-05.2006
135. Kinnally EL, Tarara ER, Mason WA, Mendoza SP, Abel K, Lyons LA, et al. Serotonin transporter expression is predicted by early life stress and is associated with disinhibited behavior in infant rhesus macaques. Genes Brain Behav (2010) 9:45-52. doi:10.1111/j.1601-183X.2009.00533.x
136. Moya PR, Wendland JR, Salemme J, Fried RL, Murphy DL. miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells. Int J Neuropsychopharmacol (2013) 16:621-9. doi:10.1017/S1461145712000454
137. Hansen KF, Obrietan K. MicroRNA as therapeutic targets for treatment of depression. Neuropsychiatr Dis Treat (2013) 9:1011-21. doi:10.2147/NDT.S34811
138. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science (2010) 329:1537-41. doi:10.1126/science.1193692
139. Perroud N, Paoloni-Giacobino A, Prada P, Olie E, Salzmann A, Nicastro R, et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry (2011) 1:e59. doi:10.1038/tp.2011.60
140. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics (2008) 3:97-106. doi:10.4161/epi.3.2.6034
141. Champagne FA. Epigenetic mechanisms and the transgenerational effects of maternal care. Front Neuroendocrinol (2008) 29:386-97. doi:10.1016/j.yfrne.2008.03.003
142. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet (2007) 8:253-62. doi:10.1038/nrg2045
143. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One (2008) 3:e3745. doi:10.1371/journal.pone.0003745
144. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab (2010) 21:214-22. doi:10.1016/j.tem.2009.12.007
145. Whitelaw NC, Whitelaw E. Transgenerational epigenetic inheritance in health and disease. Curr Opin Genet Dev (2008) 18:273-9. doi:10.1016/j.gde.2008.07.001
146. Youngson NA, Whitelaw E. Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet (2008) 9:233-57. doi:10.1146/annurev.genom.9.081307.164445
147. Radtke KM, Ruf M, Gunter HM, Dohrmann K, Schauer M, Meyer A, et al. Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Transl Psychiatry (2011) 1:e21. doi:10.1038/tp.2011.21
148. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey A, Willour VL, et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology (2010) 151:4332-43. doi:10.1210/en.2010-0225
149. Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci (2011) 31:14191-203. doi:10.1523/JNEUROSCI.1673-11.2011
150. Smalheiser NR, Lugli G, Rizavi HS, Zhang H, Torvik VI, Pandey GN, et al. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol (2011) 14(10):1315-25. doi:10.1017/S1461145710001628
151. Kawashima H, Numakawa T, Kumamaru E, Adachi N, Mizuno H, Ninomiya M, et al. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience (2010) 165:1301-11. doi:10.1016/j.neuroscience.2009.11.057
152. Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci (2009) 12:399-408. doi:10.1038/nn.2294
153. Perroud N. Suicidal ideation during antidepressant treatment: do genetic predictors exist? CNS Drugs (2011) 25:459-71. doi:10.2165/11589420-000000000-00000